Your browser doesn't support javascript.
loading
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Steger, G G; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, B L; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, A L; Singer, C F; Muss, C; Jakesz, R; Gampenrieder, S P; Zielinski, C C; Fesl, C; Gnant, M.
Afiliación
  • Steger GG; Department of Internal Medicine I, Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna.
Ann Oncol ; 25(2): 366-71, 2014 Feb.
Article en En | MEDLINE | ID: mdl-24347519

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal de Mama Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Año: 2014 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal de Mama Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Año: 2014 Tipo del documento: Article